Barclays »

Celldex Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.4M 130k 33.99
2024-06-30 $2.0M 54k 36.99
2024-03-31 $2.8M 67k 41.96
2023-12-31 $5.8M 146k 39.66
2023-09-30 $3.9M 144k 27.53
2023-06-30 $5.8M 172k 33.93
2023-03-31 $3.9M 109k 35.98
2022-12-31 $5.2M 117k 44.57
2022-09-30 $4.1M 145k 28.11
2022-06-30 $2.6M 97k 26.96
2022-03-31 $7.0M 207k 34.06
2021-12-31 $5.4M 140k 38.64
2021-09-30 $2.1M 40k 54.00
2021-06-30 $730k 22k 33.45
2021-03-31 $1.1M 55k 20.61
2020-12-31 $9.0k 500 18.00
2020-09-30 $13k 866 15.01
2020-06-30 $0 2 0.00
2019-09-30 $0 26 0.00
2019-06-30 $10k 3.9k 2.55
2019-03-31 $45k 9.1k 4.93